Cygnus GlucoWatch Launch Contingent On AutoSensor Facility Clearance
This article was originally published in The Gray Sheet
Executive Summary
Full-scale U.S. launch of Cygnus' GlucoWatch Biographer non-invasive glucose monitoring system will await FDA approval of a primary manufacturing site for the AutoSensor component, the firm says.